首页> 外文期刊>Thyroid: official journal of the American Thyroid Association >Comparison of palpation-guided fine-needle aspiration biopsy to ultrasound-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules.
【24h】

Comparison of palpation-guided fine-needle aspiration biopsy to ultrasound-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules.

机译:触诊引导的细针穿刺活检与超声引导的细针穿刺活检在甲状腺结节评估中的比较。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: Although fine-needle aspiration biopsy (FNAB) of thyroid nodules is a reliable and simple method, the diagnostic value may be limited by inadequate and false-negative results. In this prospective study, we compared palpation-guided FNAB (PGFNAB) with ultrasound-guided FNAB (UGFNAB) to establish the rates of inadequate material and cost-effectiveness. DESIGN: A total of 285 thyroid nodules in 215 patients were included in the study. Palpable nodules with the greatest diameter between 1 and 2.5 cm were included in the study. PGFNAB and UGFNAB techniques were applied to the same nodule by the same operator. Cytologic evaluations were performed by the same cytologist in a blinded fashion. To provide cost analysis, the prices obtained from different hospitals were evaluated. MAIN OUTCOME: The rates of inadequate material for PGFNAB and UGFNAB were significantly different as 32.3% and 21.4%, respectively (p = 0.004). There was significantly higher inadequate material rate in PGFNAB group for small-sized nodules (greatest nodule diameter between 10 and 15 mm) (p = 0.009), despite inadequate material rate was not significant for both procedures for larger sized nodules. False-negative results were 15.8% for PGFNAB and 5.6% for UGFNAB. Regarding cost analysis, the difference between the two methods was 20 dollars on average for each patient. CONCLUSIONS: We consider UGFNAB to be superior to PGFNAB for obtaining adequate material especially for small-sized nodules, as well as providing more accurate cytologic evaluation. Indeed, the difference between the costs of two procedures might be acceptable.
机译:目的:尽管甲状腺结节的细针穿刺活检(FNAB)是一种可靠且简单的方法,但其诊断价值可能受到不充分和假阴性结果的限制。在这项前瞻性研究中,我们将触诊引导的FNAB(PGFNAB)与超声引导的FNAB(UGFNAB)进行了比较,以确定材料不足和成本效益的比率。设计:该研究共纳入215位患者中的285个甲状腺结节。该研究包括最大直径在1至2.5厘米之间的可触及的结节。 PGFNAB和UGFNAB技术由同一操作员应用于同一结节。细胞学评估由同一位细胞学家以盲法进行。为了提供成本分析,对从不同医院获得的价格进行了评估。主要结果:PGFNAB和UGFNAB的材料不足率显着不同,分别为32.3%和21.4%(p = 0.004)。对于小结节(最大结节直径在10到15 mm之间),PGFNAB组中的材料率显着较高(p = 0.009),尽管对于较大尺寸的结节,两种方法的材料率均不显着。 PGFNAB的假阴性结果为15.8%,UGFNAB的假阴性结果为5.6%。关于成本分析,两种方法之间的差额为每位患者平均20美元。结论:我们认为UGFNAB在获得足够的材料(尤其是小结节)以及提供更准确的细胞学评估方面优于PGFNAB。确实,两个程序的成本之间的差异可能是可以接受的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号